The Medical Letter on Drugs and Therapeutics
ONLINE
ONLY
ARTICLE
November 9, 2026
View Complete Issue         Table of Contents 2019 
Comparison Chart: Antiviral Drugs for Seasonal Influenza (online only)
PDF:   US English
Disclosures & ObjectivesDisclosures & Objectives
View Complete Issue
Send Article Feedback
Disclosures
Principal Faculty
  • Jean-Marie Pflomm, Pharm.D., Editor in Chief has disclosed no relevant financial relationships.
Additional Contributor(s)
  • Corinne Z. Morrison, Pharm.D., Associate Editor has disclosed no relevant financial relationships.
Objective(s)
Upon completion of this activity, the participant will be able to:
  1. Discuss the current recommendations for antiviral treatment and prophylaxis of seasonal influenza.
  2. Compare the antiviral drugs available for treatment of influenza based on their efficacy, dosage and administration, and potential adverse effects.
  3. Determine the most appropriate regimen for treatment or prophylaxis of influenza in a particular patient.
 Select a term to see related articles  antiviral drugs   baloxavir   FluMist   influenza   oseltamivir   peramivir   Rapivab   Relenza   Tamiflu   Xofluza   zanamivir 
Med Lett Drugs Ther. 2026 Nov 9;68(1767):e180-3   doi:10.58347/tml.2026.1767c

View the Comparison Chart: Antiviral Drugs for Seasonal Influenza

Download PDF: US English

© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
arrow to previous article